MeiraGTx (MGTX) Competitors $7.65 +0.18 (+2.41%) Closing price 04:00 PM EasternExtended Trading$7.64 -0.01 (-0.07%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MGTX vs. CNTA, DNLI, IBRX, AGIO, IDYA, OCUL, HRMY, IRON, CGON, and RXRXShould you be buying MeiraGTx stock or one of its competitors? The main competitors of MeiraGTx include Centessa Pharmaceuticals (CNTA), Denali Therapeutics (DNLI), ImmunityBio (IBRX), Agios Pharmaceuticals (AGIO), IDEAYA Biosciences (IDYA), Ocular Therapeutix (OCUL), Harmony Biosciences (HRMY), Disc Medicine (IRON), CG Oncology (CGON), and Recursion Pharmaceuticals (RXRX). These companies are all part of the "pharmaceutical products" industry. MeiraGTx vs. Its Competitors Centessa Pharmaceuticals Denali Therapeutics ImmunityBio Agios Pharmaceuticals IDEAYA Biosciences Ocular Therapeutix Harmony Biosciences Disc Medicine CG Oncology Recursion Pharmaceuticals Centessa Pharmaceuticals (NASDAQ:CNTA) and MeiraGTx (NASDAQ:MGTX) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings. Do insiders & institutionals hold more shares of CNTA or MGTX? 82.0% of Centessa Pharmaceuticals shares are owned by institutional investors. Comparatively, 67.5% of MeiraGTx shares are owned by institutional investors. 7.1% of Centessa Pharmaceuticals shares are owned by insiders. Comparatively, 7.5% of MeiraGTx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is CNTA or MGTX more profitable? Centessa Pharmaceuticals has a net margin of 0.00% compared to MeiraGTx's net margin of -415.39%. Centessa Pharmaceuticals' return on equity of -40.39% beat MeiraGTx's return on equity.Company Net Margins Return on Equity Return on Assets Centessa PharmaceuticalsN/A -40.39% -29.87% MeiraGTx -415.39%-314.44%-63.28% Which has more risk & volatility, CNTA or MGTX? Centessa Pharmaceuticals has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500. Comparatively, MeiraGTx has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500. Do analysts prefer CNTA or MGTX? Centessa Pharmaceuticals currently has a consensus target price of $31.45, suggesting a potential upside of 50.86%. MeiraGTx has a consensus target price of $24.00, suggesting a potential upside of 213.73%. Given MeiraGTx's higher probable upside, analysts plainly believe MeiraGTx is more favorable than Centessa Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centessa Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 3.08MeiraGTx 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger valuation and earnings, CNTA or MGTX? MeiraGTx has higher revenue and earnings than Centessa Pharmaceuticals. Centessa Pharmaceuticals is trading at a lower price-to-earnings ratio than MeiraGTx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentessa Pharmaceuticals$6.85M407.59-$235.76M-$1.79-11.65MeiraGTx$37.92M16.23-$147.79M-$2.04-3.75 Does the media favor CNTA or MGTX? In the previous week, Centessa Pharmaceuticals had 24 more articles in the media than MeiraGTx. MarketBeat recorded 27 mentions for Centessa Pharmaceuticals and 3 mentions for MeiraGTx. MeiraGTx's average media sentiment score of 1.67 beat Centessa Pharmaceuticals' score of 1.13 indicating that MeiraGTx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centessa Pharmaceuticals 9 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive MeiraGTx 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryCentessa Pharmaceuticals beats MeiraGTx on 11 of the 17 factors compared between the two stocks. Get MeiraGTx News Delivered to You Automatically Sign up to receive the latest news and ratings for MGTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGTX vs. The Competition Export to ExcelMetricMeiraGTxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$600.94M$3.17B$5.81B$10.01BDividend YieldN/A2.28%5.29%4.53%P/E Ratio-3.7521.3475.6926.28Price / Sales16.23469.04539.36121.13Price / CashN/A45.5837.2059.76Price / Book8.7910.0511.506.41Net Income-$147.79M-$53.33M$3.28B$270.56M7 Day Performance4.79%2.18%1.30%3.01%1 Month Performance-2.92%11.91%11.25%9.74%1 Year Performance90.30%14.14%59.54%26.68% MeiraGTx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGTXMeiraGTx4.4082 of 5 stars$7.65+2.4%$24.00+213.7%+92.5%$600.94M$37.92M-3.75300Positive NewsCNTACentessa Pharmaceuticals3.4144 of 5 stars$16.79+1.4%$31.50+87.6%+26.1%$2.25B$6.85M-9.38200Positive NewsDNLIDenali Therapeutics4.3749 of 5 stars$15.27-2.4%$33.62+120.1%-38.6%$2.23B$330.53M-5.45430News CoveragePositive NewsAnalyst ForecastIBRXImmunityBio2.7051 of 5 stars$2.34+0.4%$10.75+359.4%-28.7%$2.21B$14.74M-4.87590Analyst ForecastAGIOAgios Pharmaceuticals4.2765 of 5 stars$37.71-1.2%$56.33+49.4%-15.9%$2.19B$36.50M3.43390News CoverageInsider TradeAnalyst RevisionIDYAIDEAYA Biosciences4.1398 of 5 stars$24.55-1.5%$47.10+91.9%-35.4%$2.15B$7M-6.4880Trending NewsAnalyst ForecastGap UpOCULOcular Therapeutix3.8164 of 5 stars$12.21-2.5%$17.20+40.9%+51.5%$2.12B$63.72M-9.54230News CoverageHRMYHarmony Biosciences4.5681 of 5 stars$36.89-2.8%$51.00+38.2%+0.7%$2.12B$714.73M11.90200Positive NewsIRONDisc Medicine3.0548 of 5 stars$59.650.0%$98.30+64.8%+23.0%$2.07BN/A-13.3430News CoveragePositive NewsCGONCG Oncology2.5152 of 5 stars$26.82+0.4%$54.30+102.5%-11.5%$2.04B$1.14M-15.1561Trending NewsAnalyst ForecastInsider TradeRXRXRecursion Pharmaceuticals2.4132 of 5 stars$4.70-3.3%$7.00+48.9%-22.0%$2.04B$58.84M-2.64400Positive News Related Companies and Tools Related Companies CNTA Competitors DNLI Competitors IBRX Competitors AGIO Competitors IDYA Competitors OCUL Competitors HRMY Competitors IRON Competitors CGON Competitors RXRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGTX) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MeiraGTx Holdings PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MeiraGTx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MGTX Stock Alerts